Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roundhill Russell 2000 0DTE Covered Call Strat ETF (RDTE) vs TransMedics Group Inc (TMDX) Price & Performance

Roundhill Russell 2000 0DTE Covered Call Strat ETFTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Roundhill Russell 2000 0DTE Covered Call Strat ETF vs TransMedics Group Inc — how do they compare? Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $26.09 (market cap $159.33M), while TransMedics Group Inc trades at $77.75 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 17.2× Roundhill Russell 2000 0DTE Covered Call Strat ETF's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Roundhill Russell 2000 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days and TransMedics Group Inc for 24 Days on average.

RDTETMDX
Market Cap
$159.33M$2.74B
Volume
248,058949,331
Sector
Income / Options OverlayHealth
52-Week High
$33.66$150.42
52-Week Low
$25.96$61.99
Typical Hold Time
53 Days24 Days
Enterprise Value
—$3.13B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roundhill Russell 2000 0DTE Covered Call Strat ETF

No Aura AI signal available yet.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.

The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDTE
93% Buy7% Sell
Avg holding period · 53 Days
TMDX
95% Buy5% Sell
Avg holding period · 24 Days

Top news

Latest headlines on both assets

About Roundhill Russell 2000 0DTE Covered Call Strat ETF

RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.

Read more on RDTE →

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX →